Niraparib Tosylate Monohydrate
CAS No. 1613220-15-7
Niraparib Tosylate Monohydrate ( —— )
Catalog No. M21829 CAS No. 1613220-15-7
Niraparib is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer.
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
5MG | 50 | Get Quote |
|
10MG | 71 | Get Quote |
|
25MG | 107 | Get Quote |
|
50MG | 132 | Get Quote |
|
100MG | 205 | Get Quote |
|
200MG | 309 | Get Quote |
|
500MG | 516 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNiraparib Tosylate Monohydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionNiraparib is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer.
-
DescriptionNiraparib is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer.It is used for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy.Niraparib is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1613220-15-7
-
Formula Weight510.61
-
Molecular FormulaC26H30N4O5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO.CC1=CC=C(C=C1)S(O)(=O)=O.[H][C@]1(CCCNC1)C1=CC=C(C=C1)N1C=C2C=CC=C(C(O)=N)C2=N1
-
Chemical Name2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboximidic acid 4-methylbenzene-1-sulfonic acid hydrate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
C-Peptide, dog
C-Peptide, dog is a component of proinsulin, released from pancreatic beta cells into blood together with insulin. The C-peptide of proinsulin is important for the biosynthesis of insulin but has for a long time been considered to be biologically inert.
-
1,4-Anthraquinone
1,4-Anthraquinone is an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation.
-
Amifampridine
Amifampridine works by blocking potassium channel efflux in nerve terminals so that action potential duration is increased. Ca2+ channels can then be open for a longer time and allow greater acetylcholine release to stimulate muscle at the end plate.